Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos One|January 24, 2013
Ack1: activation and regulation by allosteryKetan S Gajiwala, Karen Maegley, RoseAnn Ferre, et al.
Structure (London, England : 1993)|January 1, 2013
Insights into the aberrant activity of mutant EGFR kinase domain and drug recognitionKetan S Gajiwala, Junli Feng, Roseann Ferre, et al.
The Journal of Biological Chemistry|July 21, 2017
The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinaseKetan S Gajiwala, Neil Grodsky, Ben Bolaños, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Structure-based design of novel human Pin1 inhibitors (II)Liming Dong, Joseph Marakovits, Xinjun Hou, et al.
The Journal of Biological Chemistry|April 24, 2022
Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variantsSamantha E Greasley, Stephen Noell, Olga Plotnikova, et al.
The Journal of Biological Chemistry|February 5, 2025
Modulation of the substrate preference of a MYST acetyltransferase by a scaffold proteinRaghuvir N Sengupta, Oleg Brodsky, Patrick Bingham, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2014
Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocketChuangxing Guo, Xinjun Hou, Liming Dong, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2009
Structure-based design of novel human Pin1 inhibitors (I)Chuangxing Guo, Xinjun Hou, Liming Dong, et al.
Cell Chemical Biology|October 3, 2017
Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent InhibitorsSherry Niessen, Melissa M Dix, Sabrina Barbas, et al.
Science Advances|July 24, 2024
In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillanceYuao Zhu, Irina Yurgelonis, Stephen Noell, et al.
Pageof 2